arrow
J

James F. Howard

University of North Carolina at Chapel Hill
H指数:56
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term safety, tolerability, and efficacy of subcutaneous efgartigimod PH20 in generalized myasthenia gravis: final results from a phase 3 open-label extension study (ADAPT-SC+)

皮下注射efgartigimod PH20在全身型重症肌无力中的长期安全性、耐受性和有效性:来自一项3期开放标签扩展研究(ADAPT-SC+)的最终结果

2026-09-200
OA
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

BCMA指导的mRNA car-t细胞治疗重症肌无力: 一项安慰剂对照2b期试验的探索性生物标志物分析

2026-01-090
OAAI
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial

BCMA指导的mRNA CAR T细胞治疗重症肌无力: 一项随机,双盲,安慰剂对照的2b期试验

2026-01-090
OAAI
Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study

从静脉补体成分5抑制剂转换为皮下注射zilucoplan治疗重症肌无力:一项IIIb期、开放标签研究

2025-07-050
OA
Pain Experiences and Prescription Pain Medications Among People With Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network

在肌营养不良监测、追踪与研究网络中,特定肌营养不良患者群体的疼痛经历与处方镇痛药物使用情况

2025-06-230
OAAI
Free-breathing, non-contrast, three-dimensional whole-heart coronary magnetic resonance imaging for the identification of culprit and vulnerable atherosclerotic plaque

自由呼吸、无对比剂、三维全心冠状动脉磁共振成像在识别罪犯和易损动脉粥样硬化斑块中的应用

2025-04-220
OAAI